Takayuki Suzuki

Discovery of Ipragliflozin (ASP1941): A novel C-glucoside with benzothiophene structure as a potent and selective sodium glucose co-transporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes mellitus

Masakazu Imamura, Keita Nakanishi, Takayuki Suzuki et al. · Bioorganic & Medicinal Chemistry · 2012 · 132 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

Distinct regulation of beta 1- and beta 2-adrenergic receptors in Chinese hamster fibroblasts.

Takayuki Suzuki, Carie Nguyen, F. Nantel et al. · Molecular Pharmacology · 1992 · 110 citations

Life Sciences, Cell Biology, Pharmacology +17

Repeated sauna therapy improves myocardial perfusion in patients with chronically occluded coronary artery-related ischemia

Mitsuo Sobajima, Takashi Nozawa, Hiroyuki Ihori et al. · International Journal of Cardiology · 2012 · 58 citations

Medicine, Cardiology, Surgery +14

Role of Atrophic Tubules in Development of Interstitial Fibrosis in Microembolism-Induced Renal Failure in Rat

Takayuki Suzuki, Masato Kimura, Mitsuko Asano et al. · American Journal Of Pathology · 2001 · 57 citations · Full text

Medicine, Nephrology, Pathology +16

Synthesis and biological evaluation of C-glucosides with azulene rings as selective SGLT2 inhibitors for the treatment of type 2 diabetes mellitus: Discovery of YM543

Kazuhiro Ikegai, Masakazu Imamura, Takayuki Suzuki et al. · Bioorganic & Medicinal Chemistry · 2013 · 52 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14